453 related articles for article (PubMed ID: 28633826)
1. Optimization and characterization of ultrasound assisted preparation of curcumin-loaded solid lipid nanoparticles: Application of central composite design, thermal analysis and X-ray diffraction techniques.
Behbahani ES; Ghaedi M; Abbaspour M; Rostamizadeh K
Ultrason Sonochem; 2017 Sep; 38():271-280. PubMed ID: 28633826
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box-Behnken design and response surface methodology.
Gidwani B; Vyas A
Artif Cells Nanomed Biotechnol; 2016; 44(2):571-80. PubMed ID: 25363752
[TBL] [Abstract][Full Text] [Related]
4. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
5. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA
Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles.
Kumar R; Singh A; Sharma K; Dhasmana D; Garg N; Siril PF
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110184. PubMed ID: 31753394
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design.
Sharma JB; Bhatt S; Saini V; Kumar M
Assay Drug Dev Technol; 2021; 19(4):262-279. PubMed ID: 34000202
[No Abstract] [Full Text] [Related]
9. Preparation, Characterization, and In vitro Evaluation of Curcumin- and Resveratrol-Loaded Solid Lipid Nanoparticles.
Gumireddy A; Christman R; Kumari D; Tiwari A; North EJ; Chauhan H
AAPS PharmSciTech; 2019 Mar; 20(4):145. PubMed ID: 30887133
[TBL] [Abstract][Full Text] [Related]
10. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
Dudhipala N; Veerabrahma K
Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
[TBL] [Abstract][Full Text] [Related]
12. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
[TBL] [Abstract][Full Text] [Related]
13. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
14. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.
Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S
Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828
[TBL] [Abstract][Full Text] [Related]
17. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
18. Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation.
Sadegh Malvajerd S; Azadi A; Izadi Z; Kurd M; Dara T; Dibaei M; Sharif Zadeh M; Akbari Javar H; Hamidi M
ACS Chem Neurosci; 2019 Jan; 10(1):728-739. PubMed ID: 30335941
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Optimization of Meropenem-Loaded Solid Lipid Nanoparticles: In Vitro Evaluation and Molecular Modeling.
Mhango EKG; Kalhapure RS; Jadhav M; Sonawane SJ; Mocktar C; Vepuri S; Soliman M; Govender T
AAPS PharmSciTech; 2017 Aug; 18(6):2011-2025. PubMed ID: 27933586
[TBL] [Abstract][Full Text] [Related]
20. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size.
Ghadiri M; Fatemi S; Vatanara A; Doroud D; Najafabadi AR; Darabi M; Rahimi AA
Int J Pharm; 2012 Mar; 424(1-2):128-37. PubMed ID: 22227603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
